An exploratory cost-effectiveness analysis of methicillin-resistant Staphylococcus aureus nares PCR in pediatric pneumonia and tracheitis
Antimicrobial Stewardship & Healthcare Epidemiology · 2025 · 5 (1)
DOI: 10.1017/ash.2025.10043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 30.06.2025. Verfasst von Evan E Facer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Objective
To estimate the cost-effectiveness of methicillin-resistant Staphylococcus aureus (MRSA) nares poymerase chain reaction (PCR) use in pediatric pneumonia and tracheitis.
Methods
We built a cost-effectiveness model based on MRSA prevalence and probability of empiric treatment for MRSA pneumonia or tracheitis, with all parameters varied in sensitivity analyses. The hypothetical patient cohort was 52%. PCR was not favored in some scenarios when simultaneously varying MRSA infection prevalence and likelihood of MRSA empiric treatment. Screening becomes less favorable as MRSA PCR cost increased to the highest range value of the parameter ($88). Individual variation of MRSA colonization rates over wide ranges (0% – 30%) had lesser effects on results.
Conclusions
MRSA nares PCR use in hospitalized pediatric patients with CAP or tracheitis was generally favored when empiric MRSA empiric treatment rates are moderate or high.
Autor:innen und Institutionen
- Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
- Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
- Department of Internal Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
ORCID-Profile: Evan E Facer, Zachary Aldewereld, Kenneth J Smith
Zitieren
APA
Facer, E. E., Aldewereld, Z., Green, M. D., & Smith, K. J. (2025). An exploratory cost-effectiveness analysis of methicillin-resistant Staphylococcus aureus nares PCR in pediatric pneumonia and tracheitis. Antimicrobial Stewardship & Healthcare Epidemiology, 5(1). https://doi.org/10.1017/ash.2025.10043
Vancouver
Facer EE, Aldewereld Z, Green MD, Smith KJ. An exploratory cost-effectiveness analysis of methicillin-resistant Staphylococcus aureus nares PCR in pediatric pneumonia and tracheitis. Antimicrobial Stewardship & Healthcare Epidemiology. 2025;5(1). doi:10.1017/ash.2025.10043
BibTeX
@article{Facer2025,
author = {Facer, Evan E and Aldewereld, Zachary and Green, Michael D and Smith, Kenneth J},
title = {An exploratory cost-effectiveness analysis of methicillin-resistant Staphylococcus aureus nares PCR in pediatric pneumonia and tracheitis},
journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
year = {2025},
volume = {5},
number = {1},
doi = {10.1017/ash.2025.10043}
}
EUVIMED